Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 622

Similar articles for PubMed (Select 15361721)

1.

Community-wide vaccination with the heptavalent pneumococcal conjugate significantly alters the microbiology of acute otitis media.

Block SL, Hedrick J, Harrison CJ, Tyler R, Smith A, Findlay R, Keegan E.

Pediatr Infect Dis J. 2004 Sep;23(9):829-33.

PMID:
15361721
2.

Impact of pneumococcal conjugate vaccine and of reduction of antibiotic use on nasopharyngeal carriage of nonsusceptible pneumococci in children with acute otitis media.

Cohen R, Levy C, de La Rocque F, Gelbert N, Wollner A, Fritzell B, Bonnet E, Tetelboum R, Varon E.

Pediatr Infect Dis J. 2006 Nov;25(11):1001-7.

PMID:
17072121
3.

Effect of pneumococcal conjugate vaccine on nasopharyngeal bacterial colonization during acute otitis media.

Revai K, McCormick DP, Patel J, Grady JJ, Saeed K, Chonmaitree T.

Pediatrics. 2006 May;117(5):1823-9.

PMID:
16651345
4.

Acute otitis media due to penicillin-nonsusceptible Streptococcus pneumoniae before and after the introduction of the pneumococcal conjugate vaccine.

McEllistrem MC, Adams JM, Patel K, Mendelsohn AB, Kaplan SL, Bradley JS, Schutze GE, Kim KS, Mason EO, Wald ER.

Clin Infect Dis. 2005 Jun 15;40(12):1738-44. Epub 2005 May 11.

5.

Antibiotic-resistant Streptococcus pneumoniae in the heptavalent pneumococcal conjugate vaccine era: predictors of carriage in a multicommunity sample.

Finkelstein JA, Huang SS, Daniel J, Rifas-Shiman SL, Kleinman K, Goldmann D, Pelton SI, DeMaria A, Platt R.

Pediatrics. 2003 Oct;112(4):862-9.

PMID:
14523178
6.

Pathogens causing recurrent and difficult-to-treat acute otitis media, 2003-2006.

Pichichero ME, Casey JR, Hoberman A, Schwartz R.

Clin Pediatr (Phila). 2008 Nov;47(9):901-6. doi: 10.1177/0009922808319966. Epub 2008 Jun 16.

PMID:
18559884
7.

Impact of a conjugate vaccine on community-wide carriage of nonsusceptible Streptococcus pneumoniae in Alaska.

Moore MR, Hyde TB, Hennessy TW, Parks DJ, Reasonover AL, Harker-Jones M, Gove J, Bruden DL, Rudolph K, Parkinson A, Butler JC, Schuchat A.

J Infect Dis. 2004 Dec 1;190(11):2031-8. Epub 2004 Oct 27.

8.

Changes in frequency and pathogens causing acute otitis media in 1995-2003.

Casey JR, Pichichero ME.

Pediatr Infect Dis J. 2004 Sep;23(9):824-8.

PMID:
15361720
9.
11.

Pneumococcal serotypes from acute otitis media in rural Kentucky.

Block SL, Hedrick J, Harrison CJ, Tyler R, Smith A, Findlay R, Keegan E.

Pediatr Infect Dis J. 2002 Sep;21(9):859-65.

PMID:
12352810
12.

Pneumococcal bacteremia among infants with fever without known source before and after introduction of pneumococcal conjugate vaccine in the Basque Country of Spain.

Benito-Fernández J, Raso SM, Pocheville-Gurutzeta I, SánchezEtxaniz J, Azcunaga-Santibañez B, Capapé-Zache S.

Pediatr Infect Dis J. 2007 Aug;26(8):667-71.

PMID:
17848875
13.

Temporal trends of invasive disease due to Streptococcus pneumoniae among children in the intermountain west: emergence of nonvaccine serogroups.

Byington CL, Samore MH, Stoddard GJ, Barlow S, Daly J, Korgenski K, Firth S, Glover D, Jensen J, Mason EO, Shutt CK, Pavia AT.

Clin Infect Dis. 2005 Jul 1;41(1):21-9. Epub 2005 May 26.

14.

Predominance of nontypeable Haemophilus influenzae in children with otitis media following introduction of a 3+0 pneumococcal conjugate vaccine schedule.

Wiertsema SP, Kirkham LA, Corscadden KJ, Mowe EN, Bowman JM, Jacoby P, Francis R, Vijayasekaran S, Coates HL, Riley TV, Richmond P.

Vaccine. 2011 Jul 18;29(32):5163-70. doi: 10.1016/j.vaccine.2011.05.035. Epub 2011 May 27.

PMID:
21621576
15.

Postlicensure surveillance for pneumococcal invasive disease after use of heptavalent pneumococcal conjugate vaccine in Northern California Kaiser Permanente.

Black S, Shinefield H, Baxter R, Austrian R, Bracken L, Hansen J, Lewis E, Fireman B.

Pediatr Infect Dis J. 2004 Jun;23(6):485-9.

PMID:
15194827
16.

Etiology and antimicrobial susceptibility of middle ear fluid pathogens in Costa Rican children with otitis media before and after the introduction of the 7-valent pneumococcal conjugate vaccine in the National Immunization Program: acute otitis media microbiology in Costa Rican children.

Abdelnour A, Arguedas A, Dagan R, Soley C, Porat N, Castrejon MM, Ortega-Barria E, Colindres R, Pirçon JY, DeAntonio R, Van Dyke MK.

Medicine (Baltimore). 2015 Jan;94(2):e320. doi: 10.1097/MD.0000000000000320.

PMID:
25590837
17.

New patterns in the otopathogens causing acute otitis media six to eight years after introduction of pneumococcal conjugate vaccine.

Casey JR, Adlowitz DG, Pichichero ME.

Pediatr Infect Dis J. 2010 Apr;29(4):304-9. doi: 10.1097/INF.0b013e3181c1bc48.

18.

Efficacy of a pneumococcal conjugate vaccine against acute otitis media.

Eskola J, Kilpi T, Palmu A, Jokinen J, Haapakoski J, Herva E, Takala A, Käyhty H, Karma P, Kohberger R, Siber G, Mäkelä PH; Finnish Otitis Media Study Group.

N Engl J Med. 2001 Feb 8;344(6):403-9.

19.

Impact of conjugate vaccine on transmission of antimicrobial-resistant Streptococcus pneumoniae among Alaskan children.

Park SY, Moore MR, Bruden DL, Hyde TB, Reasonover AL, Harker-Jones M, Rudolph KM, Hurlburt DA, Parks DJ, Parkinson AJ, Schuchat A, Hennessy TW.

Pediatr Infect Dis J. 2008 Apr;27(4):335-40. doi: 10.1097/INF.0b013e318161434d.

PMID:
18316986
20.

Evolving microbiology and molecular epidemiology of acute otitis media in the pneumococcal conjugate vaccine era.

Pichichero ME, Casey JR.

Pediatr Infect Dis J. 2007 Oct;26(10 Suppl):S12-6.

PMID:
18049375
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk